With additional funding from USAID under the Health Service Delivery project (above), Jhpiego is working in Guinea to address the COVID-19 pandemic. This work is designed to ensure that essential health services—and the health care provers who offer them—remain available and safe so that the community can access health care in facilities and in the community. Key activities include: 1) supporting facilities to set-up triage/screening services at their entrances; 2) reinforcing infection prevention and control measures of providers as well as hygiene/sanitation within facilities; 3) supporting community health workers to safely continue to provide health education and services; 4) reinforcing electronic communication capacity among health managers and with facilities; 5) supporting mass communication and social behavior change communication; 6) integrating COVID-19 case reporting into the national DHIS2 health information system; 7) ensuring ongoing engagement with the national pandemic coordination mechanism; and 8) supporting capacity building of reanimation services by building on previous support to pre-service education institutions.

Funded by the Bill & Melinda Gates Foundation, this program promotes access to family planning choices in West African countries by supporting the introduction and scale-up of subcutaneous depot-medroxyprogesterone acetate (DMPA-SC). DMPA-SC is an innovative injectable contraceptive—also known as Sayana^® Press—that can dramatically expand access and choice for women. Jhpiego is working closely with the Access Collaborative to strengthen health systems to accelerate introduction and scale-up of DMPA-SC in select West African countries, including Guinea.

With funds from the Global Fund to Fight AIDS, Tuberculosis and Malaria, the Guinean Ministry of Health is supporting Jhpiego to strengthen and decentralize the national response to sexually transmitted infections, including HIV, with the goal of universal access to services. The goal of this program is to reduce new HIV infections and reduce the mortality and morbidity among people living with HIV. Jhpiego is leading the prevention of mother-to-child transmission of HIV (PMTCT) component of the program, focusing initially on consolidating gains and improving performance in PMTCT service provision followed by extension to additional sites.

This multi-country project is catalyzing the introduction and adoption pathways for quality-assured drugs to treat postpartum hemorrhage (i.e., heat-stable carbetocin, tranexamic acid and misoprostol) through engagement and coordination with country governments and key stakeholders. The project aims to reduce maternal mortality and morbidity by making sure the right drug is in the right place at the right time for the right indication. Funded by Unitaid, AMPLI-PPHI is led by Jhpiego and supported by consortium partners PATH and the International Federation of Gynaecology and Obstetrics (FIGO). In addition to operating in four target countries (the Democratic Republic of Congo, Guinea, Kenya and India), an additional 13 other influence countries are benefitting from country and learning exchanges as well as from the sharing of project learning, resources and tools. For more information, please visit the project website.